The relationship between the efficacy of talazoparib and the functional toll-like receptors 3 and 9 in triple negative breast cancer

dc.date.accessioned	2023-03-06T07:33:14Z
dc.date.available	2023-03-06T07:33:14Z
dc.date.issued	2022
dc.identifier.citation	Mol Immunol. 2022 Jan;141:280-286. doi: 10.1016/j.molimm.2021.12.007. Epub 2021 Dec 11.
dc.identifier.uri	https://hdl.handle.net/20.500.12619/100578
dc.relation.isversionof	10.1016/j.molimm.2021.12.007
dc.relation.isversionof	10.1016/j.molimm.2021.12.007
dc.title	The relationship between the efficacy of talazoparib and the functional toll-like receptors 3 and 9 in triple negative breast cancer
dc.relation.journal	Mol Immunol
dc.identifier.doi	10.1016/j.molimm.2021.12.007
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Guney Eskiler G
dc.contributor.author	Deveci Özkan A.